RxDoctor Payments DataLook up a doctor →

Vladimir Maletic

Greer, SCNPI 1336217801

Payments from drug & device makers

$2,581,905in general payments, 2019–2025

Across 2,311 payments — averaging $1117.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$801K
  • Otsuka America Pharmaceutical, Inc.$458K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$353K
  • Johnson & Johnson$226K
  • Supernus Pharmaceuticals, Inc.$163K
  • Axsome Therapeutics, Inc.$130K
  • plus $450K from 19 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)726$801,492
Otsuka America Pharmaceutical, Inc.495$458,365
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)283$352,779
Johnson & Johnson197$225,883
Supernus Pharmaceuticals, Inc.161$162,611
Axsome Therapeutics, Inc.112$130,398
Sunovion Pharmaceuticals Inc.106$114,445
Alkermes, Inc.69$97,131
H. Lundbeck A S16$69,155
E.r. Squibb & Sons, L.L.C.21$23,070
Janssen Scientific Affairs, LLC11$18,169
Alfasigma USA, Inc.7$17,355
Otsuka Pharmaceutical Development & Commercialization, Inc.7$16,040
Eisai Inc.22$15,256
Sage Therapeutics, LLC16$14,597
Takeda Pharmaceuticals U.S.A., Inc.9$11,577
Boehringer Ingelheim9$9,744
Sumitomo Pharma America, Inc.1$9,280
Neurelis, Inc.11$8,045
Janssen Global Services, LLC7$7,532
Livanova USA, Inc.3$6,151
Corium, LLC3$4,578
Noven Pharmaceuticals, Inc.1$4,248
Ironshore Pharmaceuticals Inc.14$3,685
Neurocrine Biosciences, Inc.4$320

Where these figures come from

Is this you, or does something look wrong? →